ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 60 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $508,000 | -33.8% | 135,546 | -8.6% | 0.00% | -33.3% |
| Q3 2021 | $767,000 | +75.1% | 148,305 | +44.2% | 0.00% | +50.0% |
| Q2 2021 | $438,000 | -39.0% | 102,868 | -23.9% | 0.00% | -33.3% |
| Q1 2021 | $718,000 | +28.7% | 135,212 | +30.7% | 0.00% | +50.0% |
| Q4 2020 | $558,000 | -5.1% | 103,472 | +40.5% | 0.00% | 0.0% |
| Q3 2020 | $588,000 | +58.1% | 73,653 | +98.2% | 0.00% | 0.0% |
| Q2 2020 | $372,000 | +304.3% | 37,155 | +9.9% | 0.00% | +100.0% |
| Q1 2020 | $92,000 | -92.9% | 33,822 | -96.9% | 0.00% | -75.0% |
| Q4 2019 | $1,302,000 | -57.9% | 1,084,803 | -47.1% | 0.00% | -63.6% |
| Q3 2019 | $3,095,000 | -58.1% | 2,049,668 | +11.4% | 0.01% | -59.3% |
| Q2 2019 | $7,394,000 | +28.5% | 1,839,225 | +37.4% | 0.03% | +22.7% |
| Q1 2019 | $5,756,000 | -4.1% | 1,338,630 | +28.2% | 0.02% | -18.5% |
| Q4 2018 | $6,003,000 | +11.0% | 1,044,011 | +161.7% | 0.03% | +35.0% |
| Q3 2018 | $5,409,000 | – | 398,902 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,054,864 | $8,597,000 | 5.88% |
| NEA Management Company, LLC | 9,880,999 | $80,530,000 | 4.18% |
| Abingworth LLP | 250,000 | $2,033,000 | 2.13% |
| New Leaf Venture Partners, L.L.C. | 127,041 | $1,035,000 | 0.89% |
| Iguana Healthcare Management, LLC | 200,000 | $1,630,000 | 0.66% |
| Rock Springs Capital Management LP | 765,001 | $6,235,000 | 0.46% |
| QVT Financial LP | 783,645 | $6,387,000 | 0.44% |
| Opaleye Management Inc. | 40,000 | $326,000 | 0.22% |
| Rathbones Group PLC | 450,525 | $3,672,000 | 0.20% |
| Virtus ETF Advisers LLC | 26,974 | $220,000 | 0.16% |